Drug Trial Radar · NCT03216447
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant
Last checked: Nov 20, 2026Latest source record: Jun 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Nov 23, 2017
Primary completion
Aug 31, 2023
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- Chang Gung Memorial HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Astellas Pharma Taiwan, Inc.
- First posted
- Jul 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of patient adherence and convenience to immunosuppressive agents in newly liver transplant recipients - a prospective, multi-center, open-labeled, randomized clinical trial for comparison between once-daily early conversion and twice-daily tacrolimus formulation.
Conditions
- Liver Transplantation
Interventions
AdvagrafDrug
Tacrolimus prolonged-release hard capsules (QD)
PrografDrug
Tacolimus capsules (q12h)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adherence of administration of Advagraf in newly Taiwanese (Chinese) liver transplant patients.Time frame: Visit 1 (Day 14) to Visit 6 (Day 364) - 50 weeks observation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chang Gung Memorial Hospital
Taoyuan, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.